Protective effect of ascorbic acid on netilmicin-induced lipid profile and peroxidation parameters in rabbit blood plasma

Acta Poloniae Pharmaceutica - Drug Research

Volumn 68, Issue 1, 2011, Pages 15-22

  Devbhuti, Pritesh ^a   Sikdar, Debasis ^a   Saha, Achintya ^b   Sengupta, Chandana ^a  

^a JADAVPUR UNIVERSITY   (India)

^b UNIVERSITY OF CALCUTTA   (India)

Author keywords

Ascorbic acid; Lipid peroxidation; Lipid profile; Netilmicin

Indexed keywords

4 HYDROXYNONENAL; ASCORBIC ACID; CHOLESTEROL; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; NETILMICIN; NITRIC OXIDE; PHOSPHOLIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; LIPID PEROXIDATION; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PLASMA; RABBIT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; ASCORBIC ACID; BIOLOGICAL MARKERS; LIPID METABOLISM; LIPID PEROXIDATION; LIPIDS; NETILMICIN; RABBITS; TIME FACTORS;

EID: 79551484037     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Kale R.K., Sitasawad S.L.: Radiat. Phys. Chem. 36, 361 (1990).
2. Tappel A.L.: Geriatrics 23, 97 (1968).
3. Glavind J., Hartmann S., Clemmensen J., Jessen K.E., Dan H.: Acta Pathol. Microbiol. Scand. 30, 1 (1952).
4. Hartmann D.: J. Am. Geriat. Soc. 17, 721 (1969).
5. Naito Y., Yoshikawa T., Yoshida N., Kondo M.: Drug Dis. Sci. 43, 305 (1998).
6. Dorr R.T.: Semin. Oncol. 23, 23 (1996).
7. Ohashi R., Mu H., Wang X., Yao Q., Chen Q.: J. Med. 98, 845 (2005).
8. Lewis G.F., Rader D.J.: Circ. Res. 96, 1221 (2005).
9. Tzagournis M.: Am. J. Clin. Nutr. 31, 1437 (1978).
10. Khan S.R., Ayub N., Nawab S., Shamsi T.S.: J. Coll. Physicians Surg. Pak. 18, 270 (2008)
11. Friedman P., Horkko S., Steinberg D., Witzium J. L., Dennis E. A.: J. Biol. Chem. 277, 7010 (2002).
12. Suryawanshi N.P., Bhutey A.K., Nagdeote A.N., Jadhav A.A., Manoorkar G.S.: Indian J. Clin. Biochem. 21, 126 (2006).
13. Agarwal S.K.: Indian J. Clin. Biochem. 21,181 (2006).
14. Naik P. P., Ghadge M.S., Raste A.S.: Indian J. Clin. Biochem. 21, 100 (2006).
15. Khiangte L., Vidyabati R.K., Singh M.K., Devi S.B., Singh T.R., Singh W.G.: J. Ind. Acad. Clin. Med. 8, 307 (2007).
16. Chan C. M.: Ann. Acad. Med. 34, 31 (2005).
17. th edn., p. 678, Jaypee Brothers Medical Publishers, New Delhi 2003.
18. Mingeot-Leclercq M. P., Brasseur R., Schanck A.: J. Toxicol. Environ. Health 44, 263 (1995).
19. Wang A.M., Sha S.H., Lesniak W., Schacht J.: Antimicrob. Agents Chemother. 47, 1836 (2003).
20. Mingeot-Leclercq M.P., Tulkens P.M.: Antimicrob. Agents Chemother. 43, 1003 (1999).
21. Chakraborty S., Devbhuti P., Ray S., Sengupta C., Roy K.: Acta Pol. Pharm. Drug Res. 62, 141 (2005).
22. De K., Roy K., Saha A., Sengupta C.: Acta Pol. Pharm. Drug Res. 58, 391 (2001).
23. Roy K., Rudra S., De A.U., Sengupta C.: Indian J. Pharm. Sci. 61, 44 (1999).
24. Devbhuti P., Saha A., Sengupta C.: Acta Pol. Pharm. Drug Res. 66, 363 (2009).
25. Das S., Ray R., Snehlata, Das N., Srivastava L. M.: Mol. Cell. Biochem. 285, 143 (2006).
26. Das K.K., Gupta A.D., Dhundasi S.A., Patil A. M., Das S.N., Ambekar J.G. : J. Basic Clin. Physiol. Pharmacol. 17, 29 (2006).
27. Filis K., Anastassopoulou A., Sigala F., Theodorou D., Manouras A., Leandros E., Sigalas P. et al.: Int. J. Vit. Nutr. Res. 77, 125 (2007).
28. Yousef M.I., Awad T.I., Elhag F.A., Khaled F.A.: Toxicology 235, 194 (2007).
29. Simon J.A., Hudes E.S.: J. Am. Coll. Nutr. 17, 250 (1998).
30. Fantin B., Pangon B., Potel G., Vallois J. M., Caron F., Bure A., Carbon C.: Antimicrob. Agents Chemother. 33, 767 (1989).
31. Yousef M. I.: Toxicology 207, 81 (2005).
32. Ohkawa H., Ohisi N., Yagi K.: Anal. Biochem. 95,351 (1979).
33. Kinter M.: Free Radicals-A Practical Approach, Punchard N. A., Kelly G. J. Eds., p.136, Oxford University Press, Oxford 1996.
34. Ellman G.L.: Arch. Biochem. Biophys. 82, 70 (1959).
35. Sastry K.V.H., Moudgal R.P., Mohan J., Tyagi J.S., Rao G.S.: Anal. Biochem. 306, 79 (2002).
36. Herbert K.: Lipids, in Clinical Chemistry: Theory, Analysis and Co-relation, Kaplan, L.A. and Pesce, A.J. Eds., p. 1182, C.V. Mosby, St. Louis 1984.
37. rd edn., Burtis C.A. and Ashwood E.R. Eds., p. 809, WB Saunders, Philadelphia, PA 1998.
38. Siedel J.: Clin. Chem. 29, 1073 (1983).
39. Crescenzio I.: Clin. Chem. 27, 371 (1981).
40. Mc Gowan M.W.: Clin. Chem. 29, 538 (1983).
41. Friedewald W.T., Levy R.I., Fredrickson D.S.: Clin. Chem. 18, 499 (1972).
42. Taylor S., Watts R.: Clin. Chim. Acta 73, 547 (1976).
43. Akins J.R., Waldrep K., Bernert Z.T.: Clin. Chim. Acta 184, 219 (1989).
44. Woodman D.D., Price C.P.: Clin. Chim. Acta 38, 39 (1972).
45. Esterbauer H., Zollner H., Schaur R.J.: Atlas Sci. Biochem. 1, 311 (1998).
46. Kosower E. M., Kosower N. S.: Glutathione Metabolism and Function, p.139, Raven Press, New York 1976.
47. Kelly E.E., Wagner B.A., Buettner G.R., Bums C.K.: Arch. Biochem. Biophys. 370, 97 (1999).
48. Thounaojam M., Jadeja R., Ansarullah, Devkar R., Ramachandran A.V.: J. Health Sci. 55, 413 (2009).
49. Ramkumar K.M., Vijayakumar R.S., Ponmanickam P., Velayuthaprabhu S., Archunan G., Rajaguru P.: Basic Clin. Pharmacol. Toxicol. 103, 538 (2008).
50. Vaidya H., Rajani M., Sudarsanam V., Padh H., Goyal R.: J. Nat. Med. 63, 437 (2009).
51. Lu Y., Guo Z., Di Y., Zong Y, Qu S., Tian J.: Mol. Cells 28, 175 (2009).
52. Stryer L., Ed., in Biochemistry, p. 297, Freeman and Co., New York 1988.
53. Saha A., Roy K., De K., Sengupta C.: Acta Pol. Pharm. Drug Res. 59, 65 (2002).
54. Saha A., Roy K., De K., Sengupta C.: Ind. J. Pharm. Sci. 65, 171 (2003).